• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Center's Leadership Philosophy Survey

Description: Evaluate the extent to which CFSAN managers are demonstrating values and behaviors that are embodied in the Center's Leadership Philosophy Statement. The goal of this project is to evaluate the Center's capacity building and leadership opportunities as stated in the Foods Program priority areas.

Accomplishment: Over the course of this project, the 360-degree survey was administered to 113 CFSAN managers. Following administration of the 360-degree evaluation survey, each manager and his/her supervisor received a written report of the survey findings. Each manager also had a one-on-one meeting with CFSAN’s Organizational Development Manager to review the report and discuss survey results. Results are reported both by rater groups -- self, peers, direct reports, indirect reports, and supervisor – and by average score for each question, and frequency distribution of responses for that question. Each manager was asked to develop a Behavioral Action Plan that identifies leadership behaviors to be improved using the survey results. CFSAN will continue to use this process to evaluate whether managers are demonstrating values and behaviors that are embodied in the Leadership Philosophy Statement as well as improve CFSAN’s capacity building and leadership.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Develop a 360-degree survey to evaluate the extent to which managers are demonstrating values and behaviors that are embodied in the Center's Leadership Philosophy Statement

10/31/2009

Completed 1/8/2010

B. Publish a Request for Proposal (RFP) to obtain contracting services to administer the survey. (Online administration of the survey by a third party is required to maintain confidentiality and anonymity of raters)

2/22/2010

Completed 2/22/2010

C. Award Contract

4/5/2010

Completed 4/8/2010

D. Administer survey to Deputy Office Directors and Division Directors

5/22/2010

Completed 6/18/2010

E. Give feedback to participants

6/24/2010

(9/15/2010)

Completed 9/15/2010

F. Administer survey to remaining managers

9/15/2010

(11/15/2010)

Completed 12/1/2010

G. Give feedback to remaining managers

10/15/2010

(12/15/2010)

(3/15/2011)

Completed 4/8/2011

H. Administer survey to new managers and reassess managers with a larger rating group

7/20/2011

Completed 9/15/2011

I. Give feedback to Managers

8/30/2011

(11/25/2011)

Completed 12/15/2011

J. Develop Behavior Action Plan

9/1/2011

(1/25/2012)

(6/29/2012)

Completed 6/29/2012

K. Revise the evaluation tool so that it is compatible with the revised purpose of the survey – to provide both the person being rated and senior management with information about that person's perceived leadership effectiveness

9/1/2012

Completed 9/25/2012

L. Initiate new round of surveys with revised tool

10/1/2012

(11/30/2012)

Completed 11/30/2012

Footnotes

  • The dates in italics under the milestone due dates are modified milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised dates.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.